Locations:
Search IconSearch

News & Insights

Diabetes Doesn’t Influence Long-Term Graft Patency After Heart Bypass Surgery

Diabetes Doesn’t Influence Long-Term Graft Patency After Heart Bypass

Other factors explain diabetic patients’ poorer outcomes after bypass

690×380-Mehra

Patient Preference Should Guide Postoperative AF Strategy

No clinical advantage to either rhythm or rate control

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

178489842_650x450

GAUSS-3 Yields Robust Evidence of Muscle-Related Statin Intolerance

Also finds PCSK9 inhibitor more potent than ezetimibe in statin-intolerant patients

15-RHE-961-Husni-Hero-Image-690x380pxl

ACCELERATE Shows Third Time’s No Charm for CETP Inhibitors

Trial stopped early after evacetrapib fails to budge event rate

16-HRT-294-TAVR-Hero-Image

Tackling TAVR Together: Case Study in Building a TAVR Program

How Cleveland Clinic helped a Missouri center launch its program

ACC.16

Don’t Miss These Late-Breaking Trials at ACC.16

Seven high-profile studies ranging from TAVR to lipid-lowering

Critical Limb Ischemia

Critical Limb Ischemia: National Snapshot of Its Management Holds a Few Surprises

Endovascular procedures associated with lower mortality, LOS, cost vs. surgical bypass

BackPage 8 of 17Next

Advertisement

Ad